Opening Session
Welcome
Dr. Margaret Foti
American Association for Cancer Research, Philadelphia, PA, USA
Concurrent Session 1: Shared Cyberinfrastructure for Cancer Research and Treatment
Permission not
granted for webcast
caBRAF: A caBIG-BRAF coaction for cancer bioinformatics
Dr. Rajendra Joshi
Centre for Development of Advanced Computing, Pune, India
Concurrent Session 1: Shared Cyberinfrastructure for Cancer Research and Treatment
Indo-US partnership to accelerate botanicals and biologics drug development for cancer chemoprevention: In silico drug development model
Dr. Nagi B. Kumar
H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL, USA
Concurrent Session 4: Cancer Genetics
Free
Some slides withheld
Nuclear organization: Effect of chromosome dosage?
Dr. Kundan Sengupta
Indian Institute of Science Education and Research (IISER), Pune, India
Plenary Session 1: Cancer Genomics
Interrogating the architecture of cancer genomes
Dr. Peter J. Campbell
Wellcome Trust Sanger Inst., Cambridge, England
Plenary Session 1: Cancer Genomics
Novel, founder, and recurrent germline mutations in high-penetrance cancer genes in South Asians
Dr. Rajiv Sarin
Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Mumbai, India
Plenary Session 1: Cancer Genomics
Free
Some slides withheld
Exploiting tumor suppressor mechanisms that control genome stability in new approaches to cancer therapy
Dr. Ashok R. Venkitaraman
Univ. of Cambridge, Cambridge, England
Plenary Session 1: Cancer Genomics
Free
Unknown permission
for webcast
Genome and transcriptome landscape of oral tongue squamous cell carcinoma along with matched potentially malignant lesions
Dr. Binay Panda
Ganit Labs, Institute of Bioinformatics and Applied Biotechnology, Bangalore, India
Plenary Session 2: Oral and Head/Neck Cancer
Free
Some slides withheld
Therapy: Surgery
Dr. Anil K. D'cruz
Tata Memorial Hospital, Mumbai, INDIA
Plenary Session 2: Oral and Head/Neck Cancer
Therapeutic targeting of critical pathways in head and neck cancer
Dr. Jennifer Rubin Grandis
Univ. of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Plenary Session 2: Oral and Head/Neck Cancer
Free
Unknown permission
for webcast
Radiation response-related proteins in oral squamous cell carcinomas
Dr. Tanuja R. Teni
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, India
Plenary Session 2: Oral and Head/Neck Cancer
Free
Unknown permission
for webcast
Therapy: Radiation
Dr. A Vasanthan
Cancer Institute (WIA), Chennai, India
Plenary Session 3: Cervical Cancer
Genomics of cervical cancer
Dr. Rita Mulherkar
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, India
Plenary Session 3: Cervical Cancer
Free
Some slides withheld
Treatment of cervical cancers: Modern approaches
Dr. Shyam K. Shrivastava
Tata Memorial Hospital, Mumbai, India
Plenary Session 3: Cervical Cancer
HPV16 E2 potentiates NF-κB activation induced by TNF-α through STAT3
Dr. Devarajan Karunagaran
India Inst. of Technology Madras, Chennai, India
Plenary Session 4: Breast Cancer
Epigenetics of hormone dependence
Dr. Myles A. Brown
Dana-Farber Cancer Inst., Boston, MA , USA
Plenary Session 4: Breast Cancer
Clinical genetics and genetic testing
Dr. Judy E. Garber
Dana-Farber Cancer Inst., Boston, MA, USA
Plenary Session 4: Breast Cancer
Free
Some slides withheld
Gene expression signatures in various categories of breast cancer in Indian patients
Dr. Paturu Kondaiah
Indian Institute of Science, Bangalore, India
Plenary Session 4: Breast Cancer
In vitro transformation of mammospheres generates invasive ductal adenocarcinomas harboring breast cancer cells
Dr. Annapoorni Rangarajan
Indian Institute of Science, Bangalore, India
Plenary Session 4: Breast Cancer
Free
Some slides withheld
TMEPAI: A novel drug target in breast cancer therapy and prevention
Dr. Prajjal Kanti Singha
UT Health Science Ctr. at San Antonio, San Antonio, TX , USA
Plenary Session 4: Breast Cancer
Acquisition of oxidative stress resistance during the genesis of luminal mammary progenitors is associated with a ‘switch’ in ROS control mechanisms
Dr. Nagarajan Kannan
Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada
Plenary Session 5: Cancer Prevention and Chemoprevention
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation
Dr. Raymond N. DuBois
UT MD Anderson Cancer Ctr., Houston, TX , USA
Plenary Session 5: Cancer Prevention and Chemoprevention
Treating tobacco dependence in the oncology setting: A prevention viewpoint
Dr. Ellen R. Gritz
UT MD Anderson Cancer Ctr., Houston, TX , USA
Plenary Session 5: Cancer Prevention and Chemoprevention
Screening for cervical cancer in low- and middle-income countries
Dr. Surendra S. Shastri
Tata Memorial Centre, Mumbai, India
Plenary Session 5: Cancer Prevention and Chemoprevention
Free
Unknown permission
for webcast
A Raman spectroscopy approach for classification of subsites in oral cancers: A feasibility study
Ms. Aditi Sahu
ACTREC-TMC, Mumbai, India
©2001-2011 American Association for Cancer Research | 615 Chestnut St. 17th Floor, Philadelphia, PA 19106